Colorectal cancer
IO in MSI-H, RAS-targeted agents, and ADCs reshaping metastatic CRC.
Lenses
EarlierApproval →
MRKApprovedcash ok
2026-10-02 (-15d)Company-guided
Keytruda MSI-H CRC · NCT02563002 · CRC IO franchise update
BMYApprovedcash ok
2026-11-28 (42d)Estimated
Opdivo ± Yervoy CRC · NCT02060188 · CRC IO combo update
AMGNApprovedcash ok
2026-12-09 (53d)Company-guided
Lumakras KRAS G12C · NCT05198934 · KRAS CRC combo data
RVMDPh1cash ok
2027-03-05 (139d)Estimated
RAS(ON) inhibitor CRC · NCT05786924 · RAS CRC expansion update